CA2106249A1 - Solutions for the perfusion, preservation and reperfusion of organs - Google Patents

Solutions for the perfusion, preservation and reperfusion of organs

Info

Publication number
CA2106249A1
CA2106249A1 CA002106249A CA2106249A CA2106249A1 CA 2106249 A1 CA2106249 A1 CA 2106249A1 CA 002106249 A CA002106249 A CA 002106249A CA 2106249 A CA2106249 A CA 2106249A CA 2106249 A1 CA2106249 A1 CA 2106249A1
Authority
CA
Canada
Prior art keywords
reperfusion
preservation
mmol
equivalent
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002106249A
Other languages
French (fr)
Other versions
CA2106249C (en
Inventor
Philippe Menasche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imtix Sangstat
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2106249A1 publication Critical patent/CA2106249A1/en
Application granted granted Critical
Publication of CA2106249C publication Critical patent/CA2106249C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione

Abstract

Solution de perfusion, de conservation et reperfusion d'organes. Solution unique de perfusion, stockage et reperfusion, ayant sensiblement la composition suivante : Constituant Concentration g/l mmol/litre K+ 15 ? 5 % Na+ 100 ? 10 % Mg++ 13 ? 5 % Ca++ 0.25 ? 5 % Chlorures 41.5 ? 5 % - Chlorure de calcium, 2H2O 0,037 - Chlorure de potassium 1,118 ? 5 % - Chlorure de magnésium 2,642 Histidine (base) 4,650 30 ? 10 % Mannitol 10,930 60 ? 5 % Lactobionate (acide) 28,664 80 ? 5 % Glutamate (acide) 2,942 20 ? 10 % Eau (quantité pour un litre réajusté à pH 7,30 ? 0,10 à + 20.degree.C) Osmolalité théorique 360 m Osm/kg Glutathion (réduit GSH) ou équivalent 0,5 à 10 mmol/l, (de préférence 3) le glutathion réduit, ou équivalent, étant en solution sous pression partielle d'oxygène réduite ou nulle et se maintenant sensiblement à cette valeur jusqu'à l'utilisation.Organ perfusion, preservation and reperfusion solution. Single infusion, storage and reperfusion solution, having substantially the following composition: Constituent Concentration g / l mmol / liter K + 15? 5% Na + 100? 10% Mg ++ 13? 5% Ca ++ 0.25? 5% Chlorides 41.5? 5% - Calcium chloride, 2H2O 0.037 - Potassium chloride 1.118? 5% - Magnesium chloride 2,642 Histidine (base) 4,650 30? 10% Mannitol 10,930 60? 5% Lactobionate (acid) 28,664 80? 5% Glutamate (acid) 2.942 20? 10% Water (quantity per liter readjusted to pH 7.30? 0.10 to + 20.degree.C) Theoretical osmolality 360 m Osm / kg Glutathione (reduced GSH) or equivalent 0.5 to 10 mmol / l, ( preferably 3) the reduced glutathione, or equivalent, being in solution under reduced or zero partial pressure of oxygen and remaining substantially at this value until use.

CA002106249A 1992-09-18 1993-09-15 Solutions for the perfusion, preservation and reperfusion of organs Expired - Lifetime CA2106249C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94607392A 1992-09-18 1992-09-18
US07/946,073 1992-09-18

Publications (2)

Publication Number Publication Date
CA2106249A1 true CA2106249A1 (en) 1994-03-19
CA2106249C CA2106249C (en) 2009-04-14

Family

ID=25483919

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002106249A Expired - Lifetime CA2106249C (en) 1992-09-18 1993-09-15 Solutions for the perfusion, preservation and reperfusion of organs

Country Status (9)

Country Link
AT (1) AT407216B (en)
BE (1) BE1007500A3 (en)
CA (1) CA2106249C (en)
CH (1) CH686870A5 (en)
DE (1) DE4331711C2 (en)
ES (1) ES2070089B1 (en)
FR (1) FR2695827B1 (en)
GB (1) GB2270614B (en)
IT (1) IT1272638B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527734A1 (en) * 1995-07-28 1997-01-30 Hubert Verhaag Method and device for preserving tissues and organs, in particular transplant tissues and organs
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
SE9601396D0 (en) * 1996-04-12 1996-04-12 Dieter Haeussinger New therapeutic treatment 2
DE19706111C2 (en) * 1997-02-17 1999-02-18 Fresenius Medical Care De Gmbh Solution for storage of organs
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
CN1057192C (en) * 1997-09-10 2000-10-11 上海长征医院 Method for preparing preservation liquid for various kinds of living organs and the prepns. thereof
DE19834087C1 (en) * 1998-07-29 2000-03-30 Mirzaie Sedaposhteh Massoud Aqueous preservative solution for storage of animal tissue, especially porcine heart valves, contains sodium, potassium, magnesium and calcium salts, glucose and chelate former
FR2785501B1 (en) 1998-11-10 2001-01-05 Centre Nat Rech Scient PERFUSION AND / OR PRESERVATION AND / OR REPERFUSION SOLUTION DURING ORGAN TRANSPLANTATION
GB0028414D0 (en) 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
KR20060052158A (en) * 2004-10-12 2006-05-19 니프로 가부시키가이샤 Cell-preserving solution
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
CA2910189A1 (en) * 2013-04-24 2014-10-30 Somahlution, Llc Organ and tissue preservation solutions having increased oxygen-content, stability and shelf life
WO2014179113A1 (en) * 2013-04-29 2014-11-06 Somahlution, Llc Formulations containing poly (0-2-hydroxyethyl) starch for increasing the oxygen-content, stability and shelf life of an organ and tissue preservation solution
KR102570322B1 (en) 2013-11-22 2023-08-23 마리자임, 인크. Solutions for increasing the stability and shelf life of an organ and tissue preservation solution
CN115720893B (en) * 2022-08-08 2024-02-23 四川大学华西医院 Parathyroid gland external preservation solution and preservation method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
ES2007994A6 (en) * 1988-08-16 1989-07-01 Grino Boira Jose Maria Liquid medium for infusion and preservation of organs.
US4920044A (en) * 1988-11-08 1990-04-24 The Cleveland Clinic Foundation Intracellular flush solution for preserving organs
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5104787A (en) * 1990-03-05 1992-04-14 Lindstrom Richard L Method for apparatus for a defined serumfree medical solution useful for corneal preservation
US5145771A (en) * 1990-04-12 1992-09-08 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
GB9021325D0 (en) * 1990-10-01 1990-11-14 Geistlich Soehne Ag Chemical composition
CH683485A5 (en) * 1990-11-20 1994-03-31 Pasteur Merieux Serums Vacc infusion solutions, preservation and organ perfusion.

Also Published As

Publication number Publication date
FR2695827B1 (en) 1995-07-28
FR2695827A1 (en) 1994-03-25
AT407216B (en) 2001-01-25
GB9319264D0 (en) 1993-11-03
DE4331711C2 (en) 2001-05-03
ATA189793A (en) 2000-06-15
CH686870A5 (en) 1996-07-31
ITMI931994A0 (en) 1993-09-16
ITMI931994A1 (en) 1995-03-16
GB2270614A (en) 1994-03-23
ES2070089B1 (en) 1995-12-16
CA2106249C (en) 2009-04-14
IT1272638B (en) 1997-06-26
GB2270614B (en) 1996-03-20
DE4331711A1 (en) 1994-03-24
BE1007500A3 (en) 1995-07-18
ES2070089A1 (en) 1995-05-16

Similar Documents

Publication Publication Date Title
CA2106249A1 (en) Solutions for the perfusion, preservation and reperfusion of organs
BE904831A (en) PLASMINOGEN TISSUE ACTIVATOR COMPOSITION.
FR2785501B1 (en) PERFUSION AND / OR PRESERVATION AND / OR REPERFUSION SOLUTION DURING ORGAN TRANSPLANTATION
EP0943326A4 (en) Powdery composition for nasal administration
IL162239A0 (en) Liquid composition of factor vii polypeptides
ES2058362T3 (en) CLEANING TABLET FOR DENTAL PROSTHESES.
TNSN89060A1 (en) METHOD OF PRESERVING FRESH FISH AND SEAFOOD
US4670261A (en) Parenteral alimentation solution
MY112428A (en) Peritoneal dialysis solutions containing maltodextrins and amino acids.
BE1000355A3 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CYSTEINE AND CITRIC ACID.
IL105339A0 (en) Pharmaceutical compositions containing undenatured whey protein concentrate
BE1003188A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING N-ACETYL-CYSTEINE, AND ITS APPLICATION.
DK0819436T3 (en) Pharmaceutical and dietary preparations comprising sodium, potassium, magnesium and calcium ions as well as enzyme activators
Rowley et al. Formation of hydroxyl radicals from NADH and NADPH in the presence of copper salts
SG48282A1 (en) Preparation of factor ix
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
CA2335913A1 (en) Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
Damuni et al. Specificity of the heat-stable protein inhibitor of the branched-chain α-keto acid dehydrogenase phosphatase
JPS647983B2 (en)
Abdel-Rahman et al. Effect of exogenous glutathione, glutathione reductase, chlorine dioxide, and chlorite on osmotic fragility of rat blood in vitro
RU95117286A (en) IRRIGATION SOLUTION FOR OPHTHALMIC OPERATIONS
SU1259134A1 (en) Medium for mitochondrion incubation
SU1338652A1 (en) CONCENTRATED MANIFESTATION COMPOSITION
Kunert Metabolism of sulfur‐containing amino acids in the dermatophyte Microsporum gypseum II. Acidic amino acid derivatives
RU98111171A (en) COMPOSITION FOR TREATMENT OF BOTTOM-HOLE ZONE

Legal Events

Date Code Title Description
EEER Examination request